A case of vitiligo regression in a patient with psoriasis and psoriatic arthritis receiving adalimumab therapy

A case of vitiligo regression in a patient with psoriasis and psoriatic arthritis receiving adalimumab therapy

The article discusses the common pathogenetic pathways of autoimmune skin diseases – psoriasis and vitiligo. Currently proposed treatments for vitiligo do not significantly reduce or completely restore skin pigmentation. The use of adalimumab for 6 years in a patient suffering from psoriasis, psoria...

Full description

Bibliographic Details
Main Authors: N. S. Rudneva, E. V. Natarova, V. N. Sorotskaya, T. G. Sadunashvili
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-12-01
Series:Современная ревматология
Subjects:
psoriasis
psoriatic arthritis
generalized vitiligo
adalimumab
tumor necrosis factor α inhibitor
autoimmune diseases.
Online Access:https://mrj.ima-press.net/mrj/article/view/1237

Similar Items

Similar Items